» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: The effect of the implementation of the care package for the prevention of caesarean section wound infection Design: A clinical trial with an intervention and control group, with parallel groups, randomized, was conducted on 60 patients. Settings and conduct: Patients of the gynecological surgery department are placed in two intervention and control groups. A questionnaire consisting of: patient demographic information form, patient pregnancy information form, patient surgery information form, surgical site infection checklist and REEDA tool. Participants/Inclusion and exclusion criteria: Entry conditions: not suffering from underlying diseases such as liver/severe kidney disorders/diabetes and severe anemia (Hct<33% or Hb<11g/dl), not using suppressive drugs. immune system (crotons), no history of infectious disease and severe malnutrition in the last 6 months. Conditions of non-entry: hospitalization for more than 1 week after cesarean section, fever above 38 degrees from the time of admission to 48 hours after cesarean section, abnormal bleeding in one month leading to termination of pregnancy. Intervention groups: The intervention group will be the recipients of the care package for the prevention of surgical site infection, so that pre-surgery care will be provided to the patients according to the care package. The control group will receive all the usual and routine care of the surgical department and the operating room, and the examination of the surgical incision in terms of signs of infection is similar to the intervention group, in the first 24 hours and after removing the dressing, at each time of washing the wound and the time of suture removal and day. It will be done on the 30th. Main outcome variables: wound infection
IRCTID: IRCT20170703034873N3
Loading...